These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9516407)
21. In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition. Harris JR Micron; 2002; 33(7-8):609-26. PubMed ID: 12475558 [TBL] [Abstract][Full Text] [Related]
22. The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptide. El-Agnaf OM; Guthrie DJ; Walsh DM; Irvine GB Eur J Biochem; 1998 Sep; 256(3):560-9. PubMed ID: 9780232 [TBL] [Abstract][Full Text] [Related]
24. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387 [TBL] [Abstract][Full Text] [Related]
25. Melatonin receptor type 1A gene linked to Alzheimer's disease in old age. Sulkava S; Muggalla P; Sulkava R; Ollila HM; Peuralinna T; Myllykangas L; Kaivola K; Stone DJ; Traynor BJ; Renton AE; Rivera AM; Helisalmi S; Soininen H; Polvikoski T; Hiltunen M; Tienari PJ; Huttunen HJ; Paunio T Sleep; 2018 Jul; 41(7):. PubMed ID: 29982836 [TBL] [Abstract][Full Text] [Related]
26. Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. Ono K; Hasegawa K; Yamada M; Naiki H Biol Psychiatry; 2002 Nov; 52(9):880-6. PubMed ID: 12399141 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effect of melatonin on soluble Aβ Hu C; Wang P; Zhang S; Ren L; Lv Y; Yin R; Bi J Neurol Res; 2017 Jul; 39(7):621-631. PubMed ID: 28385118 [TBL] [Abstract][Full Text] [Related]
28. Jean L; Brimijoin S; Vaux DJ J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102 [TBL] [Abstract][Full Text] [Related]
29. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. Chyan YJ; Poeggeler B; Omar RA; Chain DG; Frangione B; Ghiso J; Pappolla MA J Biol Chem; 1999 Jul; 274(31):21937-42. PubMed ID: 10419516 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells. Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246 [TBL] [Abstract][Full Text] [Related]
31. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. Cottingham MG; Hollinshead MS; Vaux DJ Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014 [TBL] [Abstract][Full Text] [Related]
32. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro. Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038 [TBL] [Abstract][Full Text] [Related]
33. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Matsuzaki K Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558 [TBL] [Abstract][Full Text] [Related]